Jeffrey Su, Ph.D., has been named vice president of bioanalytical development at Cytovance Biologics. Dr. Su will head up the bioanalytical development laboratory supporting existing and new client needs. This lab is part of the ongoing strategic expansion of the facilities to add scientific capabilities and the 1,000L Microbial, 1,000L and 5,000L Mammalian process train capacity. “I see this addition as a key placement to meet the needs of our expansion,” said Darren Head, president chief execu...